Researchers from the Brigham and Women's Hospital have come up with a test that will predict the prognosis of mesothelioma patients after surgery. In retrospective studies, the team found that expression ratios of four genes could distinguish between a good and a poor prognosis after surgery. They decided to perform another study to validate their findings.
In the new study, 120 mesothelioma patients were tested for the four gene expression pattern. The researchers also took multiple tumor samples from each patient and studied them in two different microarray platforms and two different biopsy techniques to make sure that the results were sound. The test was able to predict overall survival, showing a median prognosis of 6.9 months in the high risk group and 31.9 months in the low risk group.
If you or someone you know has been diagnosed with mesothelioma, contact the mesothelioma attorneys of Williams Kherkher at 800-781-3955.